Innovation in Digitally Enabled Clinical Trials

Hear a range of speakers from academia, industry and the charity sector discuss their experience in clinical trials, and the challenges and opportunities ahead.

Big data and new technologies have long promised to improve the efficiency, speed and patient experience of clinical trials. How can we use data to improve (remote) patient recruitment, trial design and costs, and to harness the predictive power of future trials?

Find out how partnerships, in particular with academia, can help the commercial and charity sectors realise the potential of digitally enabled clinical trials. How has the Covid-19 pandemic accelerated change and shown us what is possible?

Professor John Norrie, Director of the Edinburgh Clinical Trials Unit, University of Edinburgh: Welcome address
Professor Aziz Sheikh, Director, Usher Institute and Dean of Data, University of Edinburgh: Digitally-enabled trials: challenges and opportunities
Dr Dave Leather, Global Medical Vice President, GSK Respiratory Therapy: The Salford Lung Study: hiccups and hurdles.
Professor Nicholas Mills, Chair of Cardiology and Data Driven Innovation Lead (Health & Social Care), University of Edinburgh: Data trials using DataLoch.
Kay Boycott, Chief Executive, Asthma UK and British Lung Foundation Partnership: The use of data to support clinical improvements for patients.(holding title)
James Brook, Head of UK and Ireland Clinical, IQVIA: Virtual trials: the perspective from industry
Professor Matt Sydes, Clinical Trials and Methodology, MRC Clinical Trials Unit at UCL: Moving forward: data-enabled trials in the UK
Panel discussion
Next steps : Edinburgh Innovations contacts to take discussions further

An Edinburgh Innovations/Usher Institute event.

[matthewsydes]

At 1:07:20, I accidentally attributed Andrew Mackay's review to Graham Powell. My error. Sorry to those impacted.